These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 24102429)
1. Tumor necrosis factor-α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling. Fujihara R; Usui M; Yamamoto G; Nishii K; Tsukamoto Y; Okamatsu Y; Sato T; Asou Y; Nakashima K; Yamamoto M J Periodontal Res; 2014 Aug; 49(4):508-17. PubMed ID: 24102429 [TBL] [Abstract][Full Text] [Related]
2. Gingival epithelial cells support osteoclastogenesis by producing receptor activator of nuclear factor kappa B ligand via protein kinase A signaling. Usui M; Sato T; Yamamoto G; Okamatsu Y; Hanatani T; Moritani Y; Sano K; Yamamoto M; Nakashima K J Periodontal Res; 2016 Aug; 51(4):462-70. PubMed ID: 26432443 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N; Maeda H; Yoshimine Y; Akamine A Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Hormdee D; Nagasawa T; Kiji M; Yashiro R; Kobayashi H; Koshy G; Noguchi K; Nitta H; Ishikawa I Clin Exp Immunol; 2005 Dec; 142(3):490-7. PubMed ID: 16297161 [TBL] [Abstract][Full Text] [Related]
5. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK; Chen YL; Chang HC; Li CL; Kuo MY J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin recovers reductions in barrier function in human gingival epithelial cells stimulated with tumor necrosis factor-α. Miyagawa T; Fujita T; Yumoto H; Yoshimoto T; Kajiya M; Ouhara K; Matsuda S; Shiba H; Matsuo T; Kurihara H Arch Oral Biol; 2016 Feb; 62():64-9. PubMed ID: 26655749 [TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H; Guo J; Bringhurst FR J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438 [TBL] [Abstract][Full Text] [Related]
8. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells. Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells. Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840 [TBL] [Abstract][Full Text] [Related]
11. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
12. Human periodontal ligament cells secrete macrophage colony-stimulating factor in response to tumor necrosis factor-alpha in vitro. Yongchaitrakul T; Lertsirirangson K; Pavasant P J Periodontol; 2006 Jun; 77(6):955-62. PubMed ID: 16734568 [TBL] [Abstract][Full Text] [Related]
13. Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. Lee HJ; Jeong GS; Pi SH; Lee SI; Bae WJ; Kim SJ; Lee SK; Kim EC J Periodontal Res; 2010 Jun; 45(3):367-74. PubMed ID: 20337895 [TBL] [Abstract][Full Text] [Related]
14. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Lee SK; Lorenzo JA Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442 [TBL] [Abstract][Full Text] [Related]
15. Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway. Fukushima H; Jimi E; Kajiya H; Motokawa W; Okabe K J Dent Res; 2005 Apr; 84(4):329-34. PubMed ID: 15790738 [TBL] [Abstract][Full Text] [Related]
16. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K; Kudo A J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857 [TBL] [Abstract][Full Text] [Related]
17. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114 [TBL] [Abstract][Full Text] [Related]